UPDATE : Friday, August 23, 2019
상단여백
Invossa still effective despite mislabeling, maker claims
Kolon Life Science said that U.S. orthopedic surgeons had published a resea...
by Lee Han-soo  |  2019-08-23 20:16
라인
Vivozon finishes P3 trial for nonnarcotic analgesics
Vivozon, a local biopharmaceutical company, said Friday that it has complet...
by Lee Han-soo  |  2019-08-23 16:03
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
HLB said Thursday it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
Haim Bio said that the Ministry of Food and Drug Safety has approved its in...
by Lee Han-soo  |  2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
Peptron said it has confirmed that PT320, a Parkinson's disease treatme...
by Lee Han-soo  |  2019-08-22 17:53
라인
‘Drug firm’s pick of doctor to attend conference overseas illegal’
Pharmaceutical companies’ support for physicians to attend academic confere...
by Kim Yun-mi  |  2019-08-22 15:45
라인
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by ...
by Lee Hye-seon  |  2019-08-22 15:37
라인
Tego Science’s diabetic foot ulcer treatment gets insurance benefit
Tego Science said that Kaloderm, a homologous cell-based drug, will receive...
by Lee Han-soo  |  2019-08-22 15:34
라인
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment
Daewoong Pharmaceutical said that it has won the go-ahead for its phase 1 c...
by Lee Han-soo  |  2019-08-22 14:36
라인
K-Hospital Fair 2019 opens 3-day show in Seoul
The K-Hospital Fair 2019 kicked off its three-day run in Seoul Wednesday. ...
by Lee Han-soo  |  2019-08-21 23:36
라인
Chong Kun Dang invests ￦5 billion in Biorchestra
Chong Kun Dang Holdings said that would invest 5 billion won ($4.1 million)...
by Lee Han-soo  |  2019-08-21 16:42
라인
‘GSK’s hair loss treatment Avodart works well for Koreans’
GlaxoSmithKline (GSK) is solidifying its position in the local hair loss ma...
by Lee Han-soo  |  2019-08-20 17:46
라인
JW’s European partner launches 3rd-gen parenteral nutrition solution in EU
JW Life Science said that Baxter Pharmaceutical, its European partner, has ...
by Lee Han-soo  |  2019-08-20 17:46
라인
Genexine, Toolgen merger deal falls through
Genexine said Tuesday it has revoked the merger agreement with Toolgen beca...
by Lee Han-soo  |  2019-08-20 11:21
라인
Combo drugs: latest trend in local pharmaceuticals
Domestic pharmaceutical companies are actively developing combination drugs...
by Lee Hye-seon  |  2019-08-19 16:02
라인
Boryung to sell antihypertensive drugs in Mexico
Boryung Pharmaceutical said the company would sell its antihypertensive com...
by Lee Han-soo  |  2019-08-19 14:31
라인
Rivalry among PARP inhibitors intense in ovarian cancer treatment
Pharmaceutical firms’ war using PARP inhibitors, a group of pharmacological...
by Kim Yun-mi  |  2019-08-19 14:00
라인
Local drugmakers speed up NASH drug development
Domestic pharmaceutical companies are rushing to develop a treatment for no...
by Lee Hye-seon  |  2019-08-16 13:52
라인
Theragen Etex turns profitable after marking record Q2 sales
Theragen Etex said Tuesday that the company and its subsidiaries recorded c...
by Lee Han-soo  |  2019-08-14 17:22
라인
AstraZeneca wins expanded indication for type 2 diabetes treatment Forxiga
AstraZeneca said that it has received an expanded indication approval for F...
by Lee Han-soo  |  2019-08-14 16:17
-12345678910-
Invossa still effective despite mislabeling, maker claimsInvossa still effective despite mislabeling, maker claims
여백
Most viewed
여백
Opinion
[Reporter’s Notebook] SillaJen should be ashamed of itself
[Reporter’s Notebook] SillaJen should be ashamed of itself
[Column] Drug regulator needs adequate expertise to promote medical devices
[Column] Drug regulator needs adequate expertise to promote medical devices
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
여백
Back to Top